(Q54224173)

English

Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®. (English)

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

type 2 diabetes

0 references

cardiovascular disease in women

0 references

1 reference

based on heuristic

inferred from title

Odd Erik Johansen

6

object named as

Odd Erik Johansen

1 reference

Europe PubMed Central

26 May 2018

1

object named as

Bernard Zinman

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

author name string

Silvio E Inzucchi

2

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

Christoph Wanner

3

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

Uwe Hehnke

4

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

Jyothis T George

5

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

David Fitchett

7

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

EMPA-REG OUTCOME® investigators

8

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

publication date

30 April 2018

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

https://scigraph.springernature.com/pub.10.1007/s00125-018-4630-2

0 references

Status of women in cardiovascular clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors, treatment and prognosis in men and women with heart failure with and without diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-specific differential in risk of diabetes-related macrovascular outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of empagliflozin in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29713728

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-018-4630-2

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/29713728

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54224173&oldid=2003508600"